Guy Meyer

30.4k total citations · 7 hit papers
204 papers, 11.7k citations indexed

About

Guy Meyer is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Guy Meyer has authored 204 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Internal Medicine, 105 papers in Cardiology and Cardiovascular Medicine and 40 papers in Epidemiology. Recurrent topics in Guy Meyer's work include Venous Thromboembolism Diagnosis and Management (158 papers), Atrial Fibrillation Management and Outcomes (62 papers) and Central Venous Catheters and Hemodialysis (39 papers). Guy Meyer is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (158 papers), Atrial Fibrillation Management and Outcomes (62 papers) and Central Venous Catheters and Hemodialysis (39 papers). Guy Meyer collaborates with scholars based in France, United States and Canada. Guy Meyer's co-authors include Olivier Sanchez, Pierre‐Marie Roy, Arnaud Perrier, Stavros Konstantinides, Hervé Sors, Alok A. Khorana, Marc Carrier, Rupert Bauersachs, Marie‐Pierre Revel and Benjamin Planquette and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Guy Meyer

193 papers receiving 11.3k citations

Hit Papers

Edoxaban for the Treatmen... 2002 2026 2010 2018 2017 2002 2020 2007 2015 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
    2017 1.1k citations Nick van Es, Marc Carrier et al. profile →
  2. Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer
    2002 620 citations Guy Meyer et al. profile →
  3. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
    2020 619 citations Cecilia Becattini, Guy Meyer et al. profile →
  4. Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women
    2007 520 citations Marianne Canonico, Emmanuel Oger et al. Circulation profile →
  5. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
    2015 452 citations Guy Meyer, Rupert Bauersachs et al. profile →
  6. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
    2014 356 citations Stavros Konstantinides, Olivier Sanchez et al. European Heart Journal profile →
  7. Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH
    2018 299 citations Alok A. Khorana, Simon Noble et al. Journal of Thrombosis and Haemostasis profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Guy Meyer 9.3k 6.3k 2.2k 2.0k 1.8k 204 11.7k
Manuel Monréal 11.3k 1.2× 7.6k 1.2× 2.9k 1.3× 3.5k 1.7× 1.8k 1.0× 421 13.5k
Francesco Dentali 7.9k 0.8× 7.1k 1.1× 1.5k 0.7× 3.6k 1.8× 1.4k 0.8× 194 13.4k
Nils Kucher 7.1k 0.8× 4.4k 0.7× 1.7k 0.8× 2.1k 1.0× 1.8k 1.0× 198 10.0k
Arnaud Perrier 9.8k 1.0× 5.4k 0.8× 1.7k 0.8× 2.7k 1.3× 3.1k 1.7× 220 13.6k
Richard H. White 8.5k 0.9× 5.5k 0.9× 2.0k 0.9× 4.0k 1.9× 1.2k 0.7× 242 15.9k
Russell D. Hull 13.3k 1.4× 9.0k 1.4× 2.3k 1.1× 5.5k 2.7× 1.6k 0.9× 242 16.4k
Marc Righini 7.5k 0.8× 4.2k 0.7× 1.4k 0.6× 2.1k 1.0× 1.4k 0.8× 251 8.8k
David Jiménez 8.8k 0.9× 5.5k 0.9× 1.5k 0.7× 1.9k 0.9× 2.2k 1.2× 254 10.4k
Giancarlo Agnelli 11.7k 1.3× 8.7k 1.4× 2.6k 1.2× 3.9k 1.9× 1.2k 0.6× 180 13.9k
Graham F. Pineo 8.9k 1.0× 7.2k 1.1× 1.5k 0.7× 4.2k 2.1× 921 0.5× 116 12.1k

Countries citing papers authored by Guy Meyer

Since Specialization
Citations

This map shows the geographic impact of Guy Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Meyer more than expected).

Fields of papers citing papers by Guy Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Meyer. The network helps show where Guy Meyer may publish in the future.

Co-authorship network of co-authors of Guy Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Meyer. A scholar is included among the top collaborators of Guy Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Meyer. Guy Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Pierre‐Marie, Raphaël Le Mao, Frédéric Gagnadoux, et al.. (2023). OC 11.2 Pulmonary Embolism Diagnostic Strategies in Patients with COPD Exacerbation: Post-Hoc Analysis of the Pep Trial. Research and Practice in Thrombosis and Haemostasis. 7. 100630–100630. 1 indexed citations
2.
Falvo, Nicolas, Isabelle Mahé, Anne‐Sophie Jannot, et al.. (2023). Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued. Cancers. 15(15). 3893–3893. 5 indexed citations
3.
4.
Yannoutsos, Alexandra, Gilles Châtellier, Diane Damotte, et al.. (2021). Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature. JMV-Journal de Médecine Vasculaire. 46(2). 53–65. 7 indexed citations
5.
6.
Robert‐Ebadi, Helia, Marta Bellesini, Thomas Moumneh, et al.. (2020). External validation of the YEARS diagnostic algorithm for suspected pulmonary embolism. Journal of Thrombosis and Haemostasis. 18(12). 3289–3295. 18 indexed citations
7.
Blondon, Marc, Grégoire Le Gal, Guy Meyer, Marc Righini, & Helia Robert‐Ebadi. (2020). Age‐adjusted D‐dimer cutoff for the diagnosis of pulmonary embolism: A cost‐effectiveness analysis. Journal of Thrombosis and Haemostasis. 18(4). 865–875. 21 indexed citations
8.
Mahé, Isabelle, Isabelle Mahé, Céline Chapelle, et al.. (2020). Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study. Cancers. 12(8). 2256–2256. 18 indexed citations
9.
10.
Delmas, Clément, Nadia Aïssaoui, Nicolas Méneveau, et al.. (2020). Reperfusion therapies in pulmonary embolism–state of the art and expert opinion: A position paper from the “Unité de Soins Intensifs de Cardiologie” group of the French Society of Cardiology. Archives of cardiovascular diseases. 113(11). 749–759. 7 indexed citations
11.
Wang, Tzu‐Fei, Jeffrey I. Zwicker, Cihan Ay, et al.. (2019). The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 17(10). 1772–1778. 100 indexed citations
12.
Girard, Philippe, Andréa Penaloza, Florence Parent, et al.. (2017). Reproducibility of clinical events adjudications in a trial of venous thromboembolism prevention. Journal of Thrombosis and Haemostasis. 15(4). 662–669. 24 indexed citations
13.
Delluc, Aurélien, Darko Antić, Ramón Lecumberri, et al.. (2017). Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 15(10). 2076–2079. 50 indexed citations
14.
Roy, Pierre‐Marie, Antoine Rachas, Guy Meyer, et al.. (2016). Multifaceted Intervention to Prevent Venous Thromboembolism in Patients Hospitalized for Acute Medical Illness: A Multicenter Cluster-Randomized Trial. PLoS ONE. 11(5). e0154832–e0154832. 17 indexed citations
15.
Jiménez, David, Javier de Miguel-Dı́ez, Ricardo Guijarro, et al.. (2016). Trends in the Management and Outcomes of Acute Pulmonary Embolism. Journal of the American College of Cardiology. 67(2). 162–170. 242 indexed citations
16.
17.
Meyer, Guy. (2014). Effective diagnosis and treatment of pulmonary embolism: Improving patient outcomes. Archives of cardiovascular diseases. 107(6-7). 406–414. 20 indexed citations
18.
Meyer, Guy, Olivier Sanchez, & Benjamin Planquette. (2013). Traitement antithrombotique et cancer. La Presse Médicale. 42(9). 1239–1245. 1 indexed citations
19.
Sanchez, Olivier, et al.. (2008). Diagnostic et traitement de l’hypertension artérielle pulmonaire idiopathique en 2008. Journal of Thoracic and Cardiovascular Surgery. 4(3). 229–235. 2 indexed citations
20.
Canonico, Marianne, Emmanuel Oger, Geneviève Plu‐Bureau, et al.. (2007). Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women. Circulation. 115(7). 840–845. 520 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Monréal Breakdown of academic impact, for papers by Francesco Dentali Breakdown of academic impact, for papers by Nils Kucher Breakdown of academic impact, for papers by Arnaud Perrier Breakdown of academic impact, for papers by Richard H. White Breakdown of academic impact, for papers by Russell D. Hull Breakdown of academic impact, for papers by Marc Righini Breakdown of academic impact, for papers by David Jiménez Breakdown of academic impact, for papers by Giancarlo Agnelli Breakdown of academic impact, for papers by Graham F. Pineo
Rankless by CCL
2026